Please Wait.....
Report
Biomarkers: Technologies and Global Markets
Market Research Report I 2025-01-09 I 165 Pages I BCC Research
Description
Report Scope:
The scope of this report on the global market for biomarker technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, technology, therapeutic area and end user. The report breaks down the market into several product categories: instruments, consumables (such as reagents, kits and panels), services and software. It also segments the market by technology: genomics, proteomics, metabolomics, imaging and bioinformatics. It also examines the biomarker market across the therapeutic areas of cancer; cardiovascular, metabolic, infectious and neurodegenerative diseases; and autoimmune disorders. The end-user segments are academic institutions, pharmaceutical and biotechnology companies, clinical research organizations, hospitals and diagnostic centers.
By region, the analysis encompasses North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The report also includes profiles of leading companies and highlights industry trends, major products, mergers and acquisitions, and other collaborations or partnerships.
Report Includes:
- 34 data tables and 62 additional tables
- An up-to-date overview of the global markets and technologies for biomarkers
- Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the size and revenue growth prospects, accompanied by a market share analysis by product type, technology, therapeutic area, end user, and region
- Assessment of market dynamics such as drivers, restraints and opportunities
- Coverage of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics
- Review of patents issued for biomarker technologies and deep dive of patent data by year, technology type, application, company, assignee and applicant country
- A discussion on ESG challenges and practices in the industry
- Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
- Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
- Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., and Agilent Technologies Inc.
Executive Summary
Summary:
The global market for biomarkers was $63.7 billion in 2023 and is expected to grow at a CAGR of 13.1% during the forecast period to reach $130.2 billion by the end of 2029. The market is driven by technological advances, the growing prevalence of chronic diseases such as cancer and cardiovascular conditions, rising demand for personalized medicine, investments in R&D, the expansion of biomarker applications in drug discovery, diagnostics and clinical trials, and government initiatives supporting healthcare innovation.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Classification of Biomarkers
Examples of Biomarkers
Susceptibility/Risk Biomarkers
Diagnostic Biomarkers
Monitoring Biomarkers
Prognostic Biomarkers
Predictive Biomarkers
Pharmacodynamic (Response) Biomarkers
Safety Biomarkers
Surrogate Biomarkers/Endpoints
Discovery, Verification and Validation
Biomarker Qualification
Applications of Biomarkers
Diagnostics, Therapeutics and Disease Monitoring
Drug Discovery and Development
Clinical Trials
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Diseases
Advances in Omics and Imaging Technologies
Market Restraints
High Development Costs
Requirement for Skilled Labor
Market Opportunities
Emerging Markets
Personalized Medicine
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Clinical Trials
Clinical Trial Analysis, by Therapeutic Area
Clinical Trial Analysis, by Study Status
Clinical Trial Analysis, by Study Type
Patent Analysis
Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Biomarkers: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Services
Software
Market Analysis by Technology
Proteomics
Genomics
Imaging
Bioinformatics
Metabolomics
Market Analysis by Therapeutic Area
Cancer
Cardiovascular and Metabolic Diseases
Neurodegenerative Diseases
Infectious Diseases
Autoimmune Diseases
Other Diseases
Market Analysis by End User
Hospitals and Diagnostic Labs
Academic and Research Institutes
Pharmaceutical and Biotech Companies
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Ranking of Companies in the Biomarker Industry
Chapter 7 Sustainability in Biomarkers Technologies and Global Markets: An ESG Perspective
Sustainability in the Biomarker Market
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BAYER AG
BD
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
ILLUMINA INC.
JEOL LTD.
KONINKLIJKE PHILIPS N.V.
PROMEGA CORP.
QIAGEN
REVVITY
SHIMADZU CORP.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A : Global Market for Biomarkers, by Product Type, Through 2029
Summary Table B : Global Market for Biomarkers, by Region, Through 2029
Table 1 : Categories of Biomarkers
Table 2 : Examples of Biomarkers
Table 3 : Clinical Trials in Biomarkers, by Therapeutic Area, 2021-2024*
Table 4 : Clinical Trials in Biomarkers, by Study Status, 2021-2024*
Table 5 : Clinical Trials in Biomarkers, by Type of Study, 2021-2024*
Table 6 : Patents Issued for Biomarkers, 2021-2024*
Table 7 : Patents Issued for Biomarkers, by Applicant, 2021-2024*
Table 8 : Global Market for Biomarkers, Through 2029
Table 9 : Global Market for Biomarkers, by Product Type, Through 2029
Table 10 : Global Market for Biomarkers, by Technology, Through 2029
Table 11 : Global Market for Biomarkers, by Therapeutic Area, Through 2029
Table 12 : Global Market for Biomarkers, by End User, Through 2029
Table 13 : Global Market for Biomarkers, by Region, Through 2029
Table 14 : North American Market for Biomarkers, by Country, Through 2029
Table 15 : European Market for Biomarkers, by Country, Through 2029
Table 16 : Asia-Pacific Market for Biomarkers, by Country, Through 2029
Table 17 : RoW Market for Biomarkers, by Sub-region, Through 2029
Table 18 : Market Rankings of Leading Companies in the Biomarker Industry, 2023
Table 19 : ESG Rankings for Major Biomarker Companies, 2024*
Table 20 : Information Sources in This Report
Table 21 : Abbreviations Used in This Report
Table 22 : Abbott: Company Snapshot
Table 23 : Abbott: Financial Performance, FY 2022 and 2023
Table 24 : Abbott: Product Portfolio
Table 25 : Abbott: News/Key Developments, 2023-2024
Table 26 : Agilent Technologies Inc.: Company Snapshot
Table 27 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 28 : Agilent Technologies Inc.: Product Portfolio
Table 29 : Agilent Technologies Inc.: News/Key Developments, 2023-2024
Table 30 : Bayer AG: Company Snapshot
Table 31 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 32 : Bayer AG: Product Portfolio
Table 33 : Bayer AG: News/Key Developments, 2022-2024
Table 34 : BD: Company Snapshot
Table 35 : BD: Financial Performance, FY 2022 and 2023
Table 36 : BD: Product Portfolio
Table 37 : BD: News/Key Developments, 2024
Table 38 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 39 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 41 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 42 : Bruker: Company Snapshot
Table 43 : Bruker: Financial Performance, FY 2022 and 2023
Table 44 : Bruker: Product Portfolio
Table 45 : Bruker: News/Key Developments, 2023
Table 46 : Danaher Corp.: Company Snapshot
Table 47 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 48 : Danaher Corp.: Product Portfolio
Table 49 : Danaher Corp.: News/Key Developments, 2022-2024
Table 50 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 51 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 52 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 53 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023
Table 54 : Fujifilm Holdings Corp.: Company Snapshot
Table 55 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 56 : Fujifilm Holdings Corp.: Product Portfolio
Table 57 : GE Healthcare: Company Snapshot
Table 58 : GE Healthcare: Financial Performance, FY 2022 and 2023
Table 59 : GE Healthcare: Product Portfolio
Table 60 : GE Healthcare: News/Key Developments, 2024
Table 61 : Illumina Inc.: Company Snapshot
Table 62 : Illumina: Financial Performance, FY 2022 and 2023
Table 63 : Illumina: Product Portfolio
Table 64 : Illumina Inc.: News/Key Developments, 2024
Table 65 : JEOL Ltd.: Company Snapshot
Table 66 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 67 : JEOL Ltd.: Product Portfolio
Table 68 : JEOL Ltd.: News/Key Developments, 2023
Table 69 : Koninklijke Philips N.V.: Company Snapshot
Table 70 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 71 : Koninklijke Philips N.V.: Product Portfolio
Table 72 : Koninklijke Philips N.V.: News/Key Developments, 2022 and 2023
Table 73 : Promega Corp.: Company Snapshot
Table 74 : Promega Corp.: Product Portfolio
Table 75 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 76 : Qiagen: Company Snapshot
Table 77 : Qiagen: Financial Performance, FY 2022 and 2023
Table 78 : Qiagen: Product Portfolio
Table 79 : Qiagen: News/Key Developments, 2023
Table 80 : Revvity: Company Snapshot
Table 81 : Revvity: Financial Performance, FY 2022 and 2023
Table 82 : Revvity: Product Portfolio
Table 83 : Revvity: News/Key Developments, 2022 and 2023
Table 84 : Shimadzu Corp.: Company Snapshot
Table 85 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 86 : Shimadzu Corp.: Product Portfolio
Table 87 : Shimadzu Corp.: News/Key Developments, 2023
Table 88 : Siemens Healthineers AG: Company Snapshot
Table 89 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 90 : Siemens Healthineers AG: Product Portfolio
Table 91 : Siemens Healthineers AG: News/Key Developments, 2024
Table 92 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 93 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 94 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 95 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure A : Global Market for Biomarkers, by Product Type, 2021-2029
Summary Figure B : Global Market for Biomarkers, by Product Type, 2021-2029
Figure 1 : Snapshot of the Market Dynamics of Biomarkers
Figure 2 : Share of Global Market for Biomarkers, by Product Type, 2023
Figure 3 : Share of Global Market for Biomarkers, by Technology, 2023
Figure 4 : Share of Global Market for Biomarkers, by Therapeutic Area, 2023
Figure 5 : Share of Global Market for Biomarkers, by End User, 2023
Figure 6 : Share of Global Market for Biomarkers, by Region, 2023
Figure 7 : Share of North American Market for Biomarkers, by Country, 2023
Figure 8 : Share of European Market for Biomarkers, by Country, 2023
Figure 9 : Share of Asia-Pacific Market for Biomarkers, by Country, 2023
Figure 10 : Share of RoW Market for Biomarkers, by Sub-region, 2023
Figure 11 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 14 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 15 : Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 16 : Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 22 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 28 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 30 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 31 : Illumina: Revenue Share, by Business Unit, FY 2023
Figure 32 : Illumina: Revenue Share, by Country/Region, FY 2023
Figure 33 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 34 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 35 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
Figure 37 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 38 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 39 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 40 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 41 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 42 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
Figure 44 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
Figure 45 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security